Generate Biomedicines Overview
- Founded
- 2018
- Status
- Private
- Employees
- 78
- Latest Deal Type
- Series B
- Latest Deal Amount
- $370M
- Investors
- 9
Generate Biomedicines General Information
Description
Operator of a generative biology platform intended to invent new drugs across protein modalities and protein therapeutics. The company's platform leverages machine learning to understand the genetic code underlying the function of proteins to rapidly generate antibodies, peptides, enzymes, cell and gene therapies to meet any therapeutic need, enabling biologists to bring radically new medicines to patients.
Contact Information
Website
www.generatebiomedicines.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Biotechnology
Drug Discovery
Primary Office
- 26 Landsdowne Street
- Cambridge, MA 02139
- United States
Generate Biomedicines Timeline
Generate Biomedicines Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Later Stage VC (Series B) | 18-Nov-2021 | $370M | 00000 | 00.000 | Completed | Generating Revenue |
| 1. Later Stage VC (Series A) | 10-Sep-2020 | 0000 | 0000 | 000.00 | Completed | Generating Revenue |
Generate Biomedicines Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | 00,000,000 | 00.000000 | 00.00 | 000.00 | 000.00 | 00 | 000.00 | 00.000 |
| Series A | 00,000,000 | 00.000000 | 00 | 00 | 00 | 00 | 00.000 |
Generate Biomedicines Executive Team (8)
Generate Biomedicines Board Members (6)
| Name | Representing | Role | Since |
|---|---|---|---|
| Frances Arnold | Self | Board Member | 000 0000 |
| Gary Pisano Jr. | Self | Board Member | 000 0000 |
| Geoffrey Maltzahn Ph.D | Self | Co-Founder & Board Member | 000 0000 |
| Noubar Afeyan Ph.D | Self | Co-Founder & Chairman | 000 0000 |
| Stéphane Bancel | Self | Board Member | 000 0000 |
Generate Biomedicines Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialGenerate Biomedicines Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Alaska Permanent Fund | Sovereign Wealth Fund | Minority | 000 0000 | 000000 0 | |
| Altitude Life Science Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | |
| ARCH Venture Partners | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Fidelity Management & Research | PE/Buyout | Minority | 000 0000 | 000000 0 | |
| March Capital | Venture Capital | Minority | 000 0000 | 000000 0 |